Pharmaceutical & API manufacturing sites in Taiwan

57 drug establishments in Taiwan are registered with the US FDA; 17 (30%) list API manufacture among their operations. 52 registrant companies are identified; sites whose registrant is not resolved to a company profile are not counted. 4 published sites are matched to an EU or UK GMP certificate inspected within the last three years.

Counts are physical site addresses in the FDA's current establishment register (US-facing sites only), not headquarters and not production volume. Methodology

FDA-registered sites
57
Registered for API manufacture
17
Identified registrants
52
Current EU/UK GMP match
4

Registered operations

Drug manufacture40
Analytical testing33
Packaging21
Labelling18
API manufacture17
Sterilisation3
Relabelling1
Repackaging1

A site can register several operations, so these do not add up to the site total.

Companies headquartered in Taiwan

API manufacturing sites (17)

Other sites with EU/UK GMP documents (2)

Only sites registered with the US FDA appear, so manufacturing that serves only other markets is missing and these figures understate national capacity. A GMP match requires the certificate address to name the site's street and its city or postcode; an unmatched site is not an uncertified site.